Related Experiment Videos
Reversible middle cerebral artery occlusion in rats using an intraluminal thread technique
S Kawamura1, Y Li, M Shirasawa
1Department of Surgical Neurology, Akita, Japan.
Surgical Neurology
|May 1, 1994
Summary
For transient cerebral ischemia, reperfusion therapy is most effective within a 2-hour window. Beyond 3 hours of ischemia, infarct volume is maximal, limiting therapeutic benefit.
Area of Science:
- Neuroscience
- Cerebrovascular research
- Ischemic stroke models
Background:
- Cerebral ischemia, a leading cause of stroke, results in neuronal damage.
- Understanding the temporal dynamics of ischemic injury is crucial for developing effective treatments.
- Reperfusion therapy aims to restore blood flow but its efficacy is time-dependent.
Purpose of the Study:
- To determine the temporal profile of neuropathologic outcomes following transient cerebral ischemia.
- To establish the time window for effective reperfusion therapy in a rat model.
- To correlate ischemia duration with infarct volume and potential for therapeutic intervention.
Main Methods:
- Utilized a rat model of reversible middle cerebral artery occlusion.
- Introduced reperfusion at varying time points (1-5 hours post-occlusion).
- Included a control group with permanent middle cerebral artery occlusion.
Main Results:
- A time window of 2 hours was identified as critical for reducing infarct volume.
- Ischemia durations of 3 hours or longer resulted in maximal infarction, comparable to permanent occlusion.
- Therapeutic interventions initiated after this critical window showed limited benefit.
Conclusions:
- The therapeutic window for mitigating infarct volume in transient cerebral ischemia is narrow, approximately 2 hours.
- Prolonged ischemia (≥3 hours) leads to irreversible damage, negating the benefits of late reperfusion.
- Early intervention is paramount for successful treatment of transient cerebral ischemia and reperfusion injury.